Literature DB >> 7521272

Pancreatic cancer.

M M Murr1, M G Sarr, A J Oishi, J A van Heerden.   

Abstract

Pancreatic cancer is a devastating disease for the patient and presents challenging diagnostic and management problems for the physician. A range of serologic and radiologic studies are available for evaluation and staging of this disease. However, invasive studies, including laparotomy, are often necessary to establish the diagnosis and resectability. Despite advances in diagnostic technology that have shortened the interval between onset of symptoms and definitive treatment, no appreciable impact on survival has been demonstrated conclusively. Operative resection offers the only hope for cure, but fewer than 15 percent of patients have resectable disease at the time of diagnosis. Palliative therapy, whether operative or nonoperative, can be performed with low morbidity and provides significant relief of symptoms. Combined-modality treatment with chemotherapy and radiation therapy prolongs survival following curative resection.

Entities:  

Mesh:

Year:  1994        PMID: 7521272     DOI: 10.3322/canjclin.44.5.304

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  17 in total

1.  RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.

Authors:  Jörg-Christian Heinrich; Anne Tuukkanen; Michael Schroeder; Torsten Fahrig; Rudolf Fahrig
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-22       Impact factor: 4.553

2.  Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.

Authors:  Maja Ludvigsen; Morten Østergaard; Henrik Vorum; Christian Jacobsen; Bent Honoré
Journal:  BMC Biochem       Date:  2009-12-22       Impact factor: 4.059

Review 3.  Pancreatic cancer.

Authors:  Hemant M Kocher; Wasfi Alrawashdeh
Journal:  BMJ Clin Evid       Date:  2010-05-19

4.  Role of endoscopic ultrasound in gastrointestinal surgery.

Authors:  Biswanath P Gouda; Tarun Gupta
Journal:  Indian J Surg       Date:  2011-12-09       Impact factor: 0.656

5.  Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer.

Authors:  E E Zervox; M G Franz; K F Salhab; A E Shafii; J Menendez; W R Gower; A S Rosemurgy
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

6.  Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene.

Authors:  Hongjun Zhai; Xinwu Zhang; Xiaoli Sun; Di Zhang; Shuangyu Ma
Journal:  Dig Dis Sci       Date:  2019-09-27       Impact factor: 3.199

Review 7.  Pancreatic cancer and the FAMMM syndrome.

Authors:  Henry T Lynch; Ramon M Fusaro; Jane F Lynch; Randall Brand
Journal:  Fam Cancer       Date:  2007-11-09       Impact factor: 2.375

8.  Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.

Authors:  Erinprit K Singh; Suchitra Ravula; Chung-Mao Pan; Po-Shen Pan; Robert C Vasko; Stephanie A Lapera; Sujith V W Weerasinghe; Mary Kay H Pflum; Shelli R McAlpine
Journal:  Bioorg Med Chem Lett       Date:  2008-03-20       Impact factor: 2.823

9.  A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.

Authors:  Po-Shen Pan; Robert C Vasko; Stephanie A Lapera; Victoria A Johnson; Robert P Sellers; Chun-Chieh Lin; Chung-Mao Pan; Melinda R Davis; Veronica C Ardi; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2009-07-15       Impact factor: 3.641

10.  Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.

Authors:  Katherine E Poruk; Matthew A Firpo; Courtney L Scaife; Douglas G Adler; Lyska L Emerson; Kenneth M Boucher; Sean J Mulvihill
Journal:  Pancreas       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.